TLR3 and cancer: This synthetic dsRNA mimetic stimulates TLR3 and MDA5, affects IFN-I and IL-15 production, enhances T-cell infiltration into tumor parenchyma, and serves as a strong adjuvant for peptide cancer vaccines [194].